Antonio, I know that you saw asymmetric investing opportunity in $AMD especially when it was significantly undervalued years ago and was rewarded accordingly. One may argue valuation has caught up to $AMD since then, although recently whole semiconductor space has taken a beating. Given current climate with semiconductor business (China geopolitical tensions/ US Chip Act/ cyclical nature/ competitions such as $NVDA, $INTL), do you still feel that $AMD specifically is still the company with asymmetric investment upside? As opposed to $NVDA, $TSM, $ASML, etc.
Also, I know that $DNA was significantly overvalued when you reviewed them last year, but since then their valuation has significantly decreased, and they are still in a promising field with great financials ($2 billion cash run way, which is more comforting in current economic crisis), although not vertically integrated like $AMRS. Do you see any asymmetric upside in $DNA now?
Cool post Antonio! Simple and valuable way to think about the world and investments.
Antonio, I know that you saw asymmetric investing opportunity in $AMD especially when it was significantly undervalued years ago and was rewarded accordingly. One may argue valuation has caught up to $AMD since then, although recently whole semiconductor space has taken a beating. Given current climate with semiconductor business (China geopolitical tensions/ US Chip Act/ cyclical nature/ competitions such as $NVDA, $INTL), do you still feel that $AMD specifically is still the company with asymmetric investment upside? As opposed to $NVDA, $TSM, $ASML, etc.
Also, I know that $DNA was significantly overvalued when you reviewed them last year, but since then their valuation has significantly decreased, and they are still in a promising field with great financials ($2 billion cash run way, which is more comforting in current economic crisis), although not vertically integrated like $AMRS. Do you see any asymmetric upside in $DNA now?